Comvita Limited provided earnings guidance for the financial year ending June 30, 2017. For the period, the company expects that after tax operating loss was of $7 million. Net profit after tax expects to be approximately $9 million. after including the sale of Medihoney IP and shares in Derma Sciences Inc.